<?xml version="1.0" ?><news-item id="5C06-E67D-DBBD-15B1"><date>2014-03-14</date><title>Competition panel imposes Rs. 18-cr penalty on Bengal druggists body</title><source>The Hindu Business Line</source><author>Our Bureau</author><text><![CDATA[
Mar 13, 2014 (The Hindu Business Line:http://www.thehindubusinessline.com/ Delivered by Newstex) For restrictingsupply ofessential drugs The Competition Commission of India has imposed a penalty of Rs. 18 crore on the Bengal Chemists and Druggist Association (BCDA) for restricting the supply of essential medicines and abusing its dominant position.
The fair trade regulator also directed the BCDA and its office-bearers and executive committee members to 'seize and desist' from indulging in anti-competitive practices. In its order, CCI said, 'The commission is of the view that the said anti-competitive acts and conducts require to be penalised to cause deterrence in future among the erring entities engaged in such actions. Accordingly, it is required that the degree of punishment is scaled to the severity of the violation.'It added that, 'on this count, the position of BCDA to control the market of drugs and medicines in its area of operation is undoubted.It has come clear during the investigation that BCDA and its district and zonal committees are engaged in anti-competitive practices of directly or indirectly determining the sale prices of drugs and controlling or limiting the supply of drugs through concerted and restricted practices in violation of the Act.'PenaltyThe penalty is based on 10 per cent and seven per cent of the average of the turnover/income/receipts of the association in the last three financial years. The fine has been imposed on 79 entities including BCDA. The CCI had referred the case for an investigation after it received complaints from some chemists.

]]></text></news-item>